Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 848 entries
Sorted by: Best Match Show Resources per page
Contemplating the Importance of Toll-like Receptors I and II Regarding Human Viral Pathogenesis.

Jundishapur journal of microbiology

Saeed U, Mazoor S, Jalal N, Zahid Piracha Z.
PMID: 25763131
Jundishapur J Microbiol. 2014 Dec 06;8(1):e13348. doi: 10.5812/jjm.13348. eCollection 2015 Jan.

BACKGROUND: Toll-like receptors (TLRs) play a major role in innate immunity, since they detect conserved pathogen-associated molecular patterns (PAMPs) on a range of microbes, including viruses, leading to innate immune activation and orchestration of the adaptive immune response.OBJECTIVES: The...

Cite
Saeed U, Mazoor S, Jalal N, et al. Contemplating the Importance of Toll-like Receptors I and II Regarding Human Viral Pathogenesis. Jundishapur J Microbiol. 2014;8(1):e13348doi: 10.5812/jjm.13348.
Saeed, U., Mazoor, S., Jalal, N., & Zahid Piracha, Z. (2015). Contemplating the Importance of Toll-like Receptors I and II Regarding Human Viral Pathogenesis. Jundishapur journal of microbiology, 8(1), e13348. https://doi.org/10.5812/jjm.13348
Saeed, Umar, et al. "Contemplating the Importance of Toll-like Receptors I and II Regarding Human Viral Pathogenesis." Jundishapur journal of microbiology vol. 8,1 (2015): e13348. doi: https://doi.org/10.5812/jjm.13348
Saeed U, Mazoor S, Jalal N, Zahid Piracha Z. Contemplating the Importance of Toll-like Receptors I and II Regarding Human Viral Pathogenesis. Jundishapur J Microbiol. 2014 Dec 06;8(1):e13348. doi: 10.5812/jjm.13348. eCollection 2015 Jan. PMID: 25763131; PMCID: PMC4344769.
Copy Download .nbib Format: NLM
Current Options for the Therapy of Chronic Hepatitis B Infection.

Current infectious disease reports

Kioko Ono-Nita S, Kato N, Shiratori Y, Omata M.
PMID: 11286654
Curr Infect Dis Rep. 2001 Apr;3(2):137-142. doi: 10.1007/s11908-996-0036-2.

Until recently the only available treatment for chronic hepatitis B was interferon-alpha. Over the past few years a new class of antiviral has become available, the reverse transcriptase inhibitors. Lamivudine is a nucleoside analogue reverse transcriptase inhibitor that was...

Cite
Kioko Ono-Nita S, Kato N, Shiratori Y, et al. Current Options for the Therapy of Chronic Hepatitis B Infection. Curr Infect Dis Rep. 2001;3(2):137-142doi: 10.1007/s11908-996-0036-2.
Kioko Ono-Nita, S., Kato, N., Shiratori, Y., & Omata, M. (2001). Current Options for the Therapy of Chronic Hepatitis B Infection. Current infectious disease reports, 3(2), 137-142. https://doi.org/10.1007/s11908-996-0036-2
Kioko Ono-Nita, Suzane, et al. "Current Options for the Therapy of Chronic Hepatitis B Infection." Current infectious disease reports vol. 3,2 (2001): 137-142. doi: https://doi.org/10.1007/s11908-996-0036-2
Kioko Ono-Nita S, Kato N, Shiratori Y, Omata M. Current Options for the Therapy of Chronic Hepatitis B Infection. Curr Infect Dis Rep. 2001 Apr;3(2):137-142. doi: 10.1007/s11908-996-0036-2. PMID: 11286654.
Copy Download .nbib Format: NLM
Association of circulating CD8(+) lymphocytes to a spontaneous and interferon-alpha induced clearance of HCV.

Hepatology research : the official journal of the Japan Society of Hepatology

Bacosi M, De Angelis A, Ursitti A, Miglioresi L, Russo F, D'Innocenzo S, Ricci GL.
PMID: 12076711
Hepatol Res. 2002 Jul;23(3):163-166. doi: 10.1016/s1386-6346(01)00178-4.

The amount of copies of HCV-RNA and count of CD8(+) lymphocytes was retrospectively evaluated in 326 patients: sampling was performed in basal condition, during treatment with alpha-IFN (n=232) and post-treatment follow-up, and at the same time points in untreated...

Cite
Bacosi M, De Angelis A, Ursitti A, et al. Association of circulating CD8(+) lymphocytes to a spontaneous and interferon-alpha induced clearance of HCV. Hepatol Res. 2002;23(3):163-166doi: 10.1016/s1386-6346(01)00178-4.
Bacosi, M., De Angelis, A., Ursitti, A., Miglioresi, L., Russo, F., D'Innocenzo, S., & Ricci, G. L. (2002). Association of circulating CD8(+) lymphocytes to a spontaneous and interferon-alpha induced clearance of HCV. Hepatology research : the official journal of the Japan Society of Hepatology, 23(3), 163-166. https://doi.org/10.1016/s1386-6346(01)00178-4
Bacosi, M, et al. "Association of circulating CD8(+) lymphocytes to a spontaneous and interferon-alpha induced clearance of HCV." Hepatology research : the official journal of the Japan Society of Hepatology vol. 23,3 (2002): 163-166. doi: https://doi.org/10.1016/s1386-6346(01)00178-4
Bacosi M, De Angelis A, Ursitti A, Miglioresi L, Russo F, D'Innocenzo S, Ricci GL. Association of circulating CD8(+) lymphocytes to a spontaneous and interferon-alpha induced clearance of HCV. Hepatol Res. 2002 Jul;23(3):163-166. doi: 10.1016/s1386-6346(01)00178-4. PMID: 12076711.
Copy Download .nbib Format: NLM
Pharmacodynamic aspects of peptide administration biological response modifiers.

Advanced drug delivery reviews

Talmadge JE.
PMID: 10837664
Adv Drug Deliv Rev. 1998 Sep 07;33(3):241-252. doi: 10.1016/s0169-409x(98)00032-5.

Cytokines, growth factors and other recombinant proteins have been one of the most rapidly growing areas of pharmaceuticals. Further, the development of these bio-engineered drugs is occurring at an astonishing pace with rapid preclinical and clinical development and licensing...

Cite
Talmadge JE. Pharmacodynamic aspects of peptide administration biological response modifiers. Adv Drug Deliv Rev. 1998;33(3):241-252doi: 10.1016/s0169-409x(98)00032-5.
Talmadge, J. E. (1998). Pharmacodynamic aspects of peptide administration biological response modifiers. Advanced drug delivery reviews, 33(3), 241-252. https://doi.org/10.1016/s0169-409x(98)00032-5
Talmadge. "Pharmacodynamic aspects of peptide administration biological response modifiers." Advanced drug delivery reviews vol. 33,3 (1998): 241-252. doi: https://doi.org/10.1016/s0169-409x(98)00032-5
Talmadge JE. Pharmacodynamic aspects of peptide administration biological response modifiers. Adv Drug Deliv Rev. 1998 Sep 07;33(3):241-252. doi: 10.1016/s0169-409x(98)00032-5. PMID: 10837664.
Copy Download .nbib Format: NLM
[Autologous hematopoietic stem cell transplantation in chronic myeloid leukaemia with different clinical stages].

Magyar onkologia

Gopcsa L, Barta A, Bányai A, Földi J, Kalász L, Pajor L, Gidáli J, Pálóczi K.
PMID: 12050722
Magy Onkol. 2001;45(1):9-13. doi: HUON.2001.45.1.0009.

For most chronic myeloid leukaemia patients the option of a potentially curative allogeneic stem cell transplantation is not available because of age or lack of donor. Alternative therapy with interferon-alpha appears to prolong survival but is probably not curative....

Cite
Gopcsa L, Barta A, Bányai A, et al. Autológ hemopoetikus ôssejt-transzplantáció eredményei chronicus myeloid leukaemiában. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukaemia with different clinical stages]. Magy Onkol. 2001;45(1):9-13doi: HUON.2001.45.1.0009.
Gopcsa, L., Barta, A., Bányai, A., Földi, J., Kalász, L., Pajor, L., Gidáli, J., & Pálóczi, K. (2001). Autológ hemopoetikus ôssejt-transzplantáció eredményei chronicus myeloid leukaemiában. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukaemia with different clinical stages]. Magyar onkologia, 45(1), 9-13. https://doi.org/HUON.2001.45.1.0009
Gopcsa, L, et al. "Autológ hemopoetikus ôssejt-transzplantáció eredményei chronicus myeloid leukaemiában." [Autologous hematopoietic stem cell transplantation in chronic myeloid leukaemia with different clinical stages]. Magyar onkologia vol. 45,1 (2001): 9-13. doi: https://doi.org/HUON.2001.45.1.0009
Gopcsa L, Barta A, Bányai A, Földi J, Kalász L, Pajor L, Gidáli J, Pálóczi K. Autológ hemopoetikus ôssejt-transzplantáció eredményei chronicus myeloid leukaemiában. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukaemia with different clinical stages]. Magy Onkol. 2001;45(1):9-13. doi: HUON.2001.45.1.0009. Hungarian. PMID: 12050722.
Copy Download .nbib Format: NLM
Low complication rate during intraperitoneal therapy through a totally implanted peritoneal access port in patients with ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Nanninga AG, Willemse PH, Boonstra H, De Vries EG.
PMID: 11576244
Int J Gynecol Cancer. 1992 Mar;2(2):107-110. doi: 10.1046/j.1525-1438.1992.02020107.x.

Fifty-three patients with histologically proven ovarian cancer were treated with intraperitoneally administered cisplatin or human recombinant interferon-alpha through a totally implanted peritoneal access port. A total of 281 treatment courses were given. No complications related to surgical implantation of...

Cite
Nanninga AG, Willemse PH, Boonstra H, et al. Low complication rate during intraperitoneal therapy through a totally implanted peritoneal access port in patients with ovarian cancer. Int J Gynecol Cancer. 1992;2(2):107-110doi: 10.1046/j.1525-1438.1992.02020107.x.
Nanninga, A. G., Willemse, P. H., Boonstra, H., & De Vries, E. G. (1992). Low complication rate during intraperitoneal therapy through a totally implanted peritoneal access port in patients with ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2(2), 107-110. https://doi.org/10.1046/j.1525-1438.1992.02020107.x
Nanninga, A.G., et al. "Low complication rate during intraperitoneal therapy through a totally implanted peritoneal access port in patients with ovarian cancer." International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 2,2 (1992): 107-110. doi: https://doi.org/10.1046/j.1525-1438.1992.02020107.x
Nanninga AG, Willemse PH, Boonstra H, De Vries EG. Low complication rate during intraperitoneal therapy through a totally implanted peritoneal access port in patients with ovarian cancer. Int J Gynecol Cancer. 1992 Mar;2(2):107-110. doi: 10.1046/j.1525-1438.1992.02020107.x. PMID: 11576244.
Copy Download .nbib Format: NLM
Clinical trials of immunotherapy for advanced prostate cancer.

Urologic oncology

Kuratsukuri K, Nishisaka N, Jones RF, Wang CY, Haas GP.
PMID: 11008095
Urol Oncol. 2000 Nov 01;5(6):265-273. doi: 10.1016/s1078-1439(00)00086-7.

There is a lack of effective therapeutic regimens for advanced hormone-refractory prostate cancer (HRPC). Recent combination regimens of chemotherapy have improved management of HRPC. Neither systemic chemotherapy nor radiation regimens have significantly improved survival. Conventional systemic cytokine therapy has...

Cite
Kuratsukuri K, Nishisaka N, Jones RF, et al. Clinical trials of immunotherapy for advanced prostate cancer. Urol Oncol. 2000;5(6):265-273doi: 10.1016/s1078-1439(00)00086-7.
Kuratsukuri, K., Nishisaka, N., Jones, R. F., Wang, C. Y., & Haas, G. P. (2000). Clinical trials of immunotherapy for advanced prostate cancer. Urologic oncology, 5(6), 265-273. https://doi.org/10.1016/s1078-1439(00)00086-7
Kuratsukuri, et al. "Clinical trials of immunotherapy for advanced prostate cancer." Urologic oncology vol. 5,6 (2000): 265-273. doi: https://doi.org/10.1016/s1078-1439(00)00086-7
Kuratsukuri K, Nishisaka N, Jones RF, Wang CY, Haas GP. Clinical trials of immunotherapy for advanced prostate cancer. Urol Oncol. 2000 Nov 01;5(6):265-273. doi: 10.1016/s1078-1439(00)00086-7. PMID: 11008095.
Copy Download .nbib Format: NLM
Production of the Cytokines by Blood Leukocytes, Activated with Cycloferon.

Russian journal of immunology : RJI : official journal of Russian Society of Immunology

Mendelenko MM, Kravchenko JN, Agadjanyan KV, Kravchenko AI.
PMID: 12687236
Russ J Immunol. 2001 Dec;6(4):377-382.

Our investigation is an attempt to confirm the probability to use the cycloferon for the extracorporeal immunopharmacotherapy. For this aim the leukocytes, obtained from 5 ml of venous blood of 17 healthy individuals, were stimulated by different doses of...

Cite
Mendelenko MM, Kravchenko JN, Agadjanyan KV, et al. Production of the Cytokines by Blood Leukocytes, Activated with Cycloferon. Russ J Immunol. 2001;6(4):377-382
Mendelenko, M. M., Kravchenko, J. N., Agadjanyan, K. V., & Kravchenko, A. I. (2001). Production of the Cytokines by Blood Leukocytes, Activated with Cycloferon. Russian journal of immunology : RJI : official journal of Russian Society of Immunology, 6(4), 377-382.
Mendelenko, Mark M., et al. "Production of the Cytokines by Blood Leukocytes, Activated with Cycloferon." Russian journal of immunology : RJI : official journal of Russian Society of Immunology vol. 6,4 (2001): 377-382.
Mendelenko MM, Kravchenko JN, Agadjanyan KV, Kravchenko AI. Production of the Cytokines by Blood Leukocytes, Activated with Cycloferon. Russ J Immunol. 2001 Dec;6(4):377-382. PMID: 12687236.
Copy Download .nbib Format: NLM
Intracerebral Meningiomas.

Current treatment options in neurology

Chamberlain MC.
PMID: 15157407
Curr Treat Options Neurol. 2004 Jul;6(4):297-305. doi: 10.1007/s11940-004-0029-0.

Meningiomas are extra-axial brain tumors of middle to late adult life, and they have a female predominance. Overall, 90% of meningiomas are benign, 6% are atypical, and 2% are malignant. Most patients diagnosed with a meningioma decide to have...

Cite
Chamberlain MC. Intracerebral Meningiomas. Curr Treat Options Neurol. 2004;6(4):297-305doi: 10.1007/s11940-004-0029-0.
Chamberlain, M. C. (2004). Intracerebral Meningiomas. Current treatment options in neurology, 6(4), 297-305. https://doi.org/10.1007/s11940-004-0029-0
Chamberlain, Marc C.. "Intracerebral Meningiomas." Current treatment options in neurology vol. 6,4 (2004): 297-305. doi: https://doi.org/10.1007/s11940-004-0029-0
Chamberlain MC. Intracerebral Meningiomas. Curr Treat Options Neurol. 2004 Jul;6(4):297-305. doi: 10.1007/s11940-004-0029-0. PMID: 15157407.
Copy Download .nbib Format: NLM
Cotreatment with interferon-alpha and -gamma reduces liver fibrosis in a rat model.

Hepatology research : the official journal of the Japan Society of Hepatology

Takahara T, Sugiyama K, Zhang LP, Ando O, Fujii M, Yata Y, Bo J, Xue F, Minemura M, Watanabe A.
PMID: 15036071
Hepatol Res. 2004 Mar;28(3):146-154. doi: 10.1016/j.hepres.2003.11.003.

Background/Aims: Interferon-alpha is used widely to treat viral hepatitis. Interferon-gamma modulates a system attacking infected cells and also has an anti-fibrotic effect. A treatment with interferon-alpha and -gamma has undergone trials in eliminating hepatitis C virus. We investigated effects...

Cite
Takahara T, Sugiyama K, Zhang LP, et al. Cotreatment with interferon-alpha and -gamma reduces liver fibrosis in a rat model. Hepatol Res. 2004;28(3):146-154doi: 10.1016/j.hepres.2003.11.003.
Takahara, T., Sugiyama, K., Zhang, L. P., Ando, O., Fujii, M., Yata, Y., Bo, J., Xue, F., Minemura, M., & Watanabe, A. (2004). Cotreatment with interferon-alpha and -gamma reduces liver fibrosis in a rat model. Hepatology research : the official journal of the Japan Society of Hepatology, 28(3), 146-154. https://doi.org/10.1016/j.hepres.2003.11.003
Takahara, Terumi, et al. "Cotreatment with interferon-alpha and -gamma reduces liver fibrosis in a rat model." Hepatology research : the official journal of the Japan Society of Hepatology vol. 28,3 (2004): 146-154. doi: https://doi.org/10.1016/j.hepres.2003.11.003
Takahara T, Sugiyama K, Zhang LP, Ando O, Fujii M, Yata Y, Bo J, Xue F, Minemura M, Watanabe A. Cotreatment with interferon-alpha and -gamma reduces liver fibrosis in a rat model. Hepatol Res. 2004 Mar;28(3):146-154. doi: 10.1016/j.hepres.2003.11.003. PMID: 15036071.
Copy Download .nbib Format: NLM
[Head and neck hemangiomas: how and when to treat].

Shanghai kou qiang yi xue = Shanghai journal of stomatology

Zheng JW, Wang YA, Zhou GY, Zhu HG, Ye WM, Zhang ZY.
PMID: 17924011
Shanghai Kou Qiang Yi Xue. 2007 Aug;16(4):337-42.

Hemangiomas are common benign vascular tumors of infancy characterized by a proliferative growth phase followed by very slow inevitable regression (involutive phase) between one to ten years of age, about 60% to 70% of the lesions are found in...

Cite
Zheng JW, Wang YA, Zhou GY, et al. [Head and neck hemangiomas: how and when to treat]. Shanghai Kou Qiang Yi Xue. 2007;16(4):337-42
Zheng, J. W., Wang, Y. A., Zhou, G. Y., Zhu, H. G., Ye, W. M., & Zhang, Z. Y. (2007). [Head and neck hemangiomas: how and when to treat]. Shanghai kou qiang yi xue = Shanghai journal of stomatology, 16(4), 337-42.
Zheng, Jia-wei, et al. "[Head and neck hemangiomas: how and when to treat]." Shanghai kou qiang yi xue = Shanghai journal of stomatology vol. 16,4 (2007): 337-42.
Zheng JW, Wang YA, Zhou GY, Zhu HG, Ye WM, Zhang ZY. [Head and neck hemangiomas: how and when to treat]. Shanghai Kou Qiang Yi Xue. 2007 Aug;16(4):337-42. Chinese. PMID: 17924011.
Copy Download .nbib Format: NLM
Effect of induced pyometra on luteal lifespan and uterine fluid concentrations of prostaglandins and interferons in cows.

Theriogenology

Davidson JA, Wright DJ, Archbald LF, Klapstein E, Gottshall SL, Hansen PJ.
PMID: 16727809
Theriogenology. 1996 Jan 15;45(2):459-70. doi: 10.1016/0093-691x(95)00382-i.

The objective was to determine whether occurrence of persistent corpora lutea in cows with pyometra could be explained by accumulation of prostaglandins and interferons in the uterus. Pyometra was induced by treatment with hCG, followed by intrauterine infusions of...

Cite
Davidson JA, Wright DJ, Archbald LF, et al. Effect of induced pyometra on luteal lifespan and uterine fluid concentrations of prostaglandins and interferons in cows. Theriogenology. 1996;45(2):459-70doi: 10.1016/0093-691x(95)00382-i.
Davidson, J. A., Wright, D. J., Archbald, L. F., Klapstein, E., Gottshall, S. L., & Hansen, P. J. (1996). Effect of induced pyometra on luteal lifespan and uterine fluid concentrations of prostaglandins and interferons in cows. Theriogenology, 45(2), 459-70. https://doi.org/10.1016/0093-691x(95)00382-i
Davidson, J A, et al. "Effect of induced pyometra on luteal lifespan and uterine fluid concentrations of prostaglandins and interferons in cows." Theriogenology vol. 45,2 (1996): 459-70. doi: https://doi.org/10.1016/0093-691x(95)00382-i
Davidson JA, Wright DJ, Archbald LF, Klapstein E, Gottshall SL, Hansen PJ. Effect of induced pyometra on luteal lifespan and uterine fluid concentrations of prostaglandins and interferons in cows. Theriogenology. 1996 Jan 15;45(2):459-70. doi: 10.1016/0093-691x(95)00382-i. PMID: 16727809.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 848 entries